 | • レポートコード：MRC2-11QY02590 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗精神病薬のグローバル市場について調査・分析したレポートです。種類別（初回抗精神病薬、2回目抗精神病薬、3回目抗精神病薬）市場規模、用途別（統合失調症、双極性障害、単極性うつ病、認知症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗精神病薬の競争状況、市場シェア ・世界の抗精神病薬市場：種類別市場規模 2015年-2020年（初回抗精神病薬、2回目抗精神病薬、3回目抗精神病薬） ・世界の抗精神病薬市場：種類別市場規模予測 2021年-2026年（初回抗精神病薬、2回目抗精神病薬、3回目抗精神病薬） ・世界の抗精神病薬市場：用途別市場規模 2015年-2020年（統合失調症、双極性障害、単極性うつ病、認知症、その他） ・世界の抗精神病薬市場：用途別市場規模予測 2021年-2026年（統合失調症、双極性障害、単極性うつ病、認知症、その他） ・北米の抗精神病薬市場分析：米国、カナダ ・ヨーロッパの抗精神病薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗精神病薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗精神病薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗精神病薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnson、Actavis Generics、Alkermes、Bristol-Myers Squibb ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
Market Analysis and Insights: Global Antipsychotic Drugs Market
The global Antipsychotic Drugs market size is projected to reach US$ 13470 million by 2026, from US$ 13020 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Antipsychotic Drugs Scope and Market Size
Antipsychotic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antipsychotic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antipsychotic Drugs market is segmented into
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
Segment by Application, the Antipsychotic Drugs market is segmented into
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Regional and Country-level Analysis
The Antipsychotic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antipsychotic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antipsychotic Drugs Market Share Analysis
Antipsychotic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antipsychotic Drugs business, the date to enter into the Antipsychotic Drugs market, Antipsychotic Drugs product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Actavis Generics
Alkermes
Bristol-Myers Squibb
…
1 Study Coverage
1.1 Antipsychotic Drugs Product Introduction
1.2 Market Segments
1.3 Key Antipsychotic Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antipsychotic Drugs Market Size Growth Rate by Type
1.4.2 First Antipsychotic Drugs
1.4.3 Second Antipsychotic Drugs
1.4.4 Third Antipsychotic Drugs
1.5 Market by Application
1.5.1 Global Antipsychotic Drugs Market Size Growth Rate by Application
1.5.2 Schizophrenia
1.5.3 Bipolar Disorder
1.5.4 Unipolar Depression
1.5.5 Dementia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antipsychotic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antipsychotic Drugs Revenue 2015-2026
2.1.2 Global Antipsychotic Drugs Sales 2015-2026
2.2 Global Antipsychotic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antipsychotic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antipsychotic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antipsychotic Drugs Competitor Landscape by Players
3.1 Antipsychotic Drugs Sales by Manufacturers
3.1.1 Antipsychotic Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antipsychotic Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antipsychotic Drugs Revenue by Manufacturers
3.2.1 Antipsychotic Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antipsychotic Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antipsychotic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antipsychotic Drugs Revenue in 2019
3.2.5 Global Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antipsychotic Drugs Price by Manufacturers
3.4 Antipsychotic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antipsychotic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antipsychotic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antipsychotic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antipsychotic Drugs Market Size by Type (2015-2020)
4.1.1 Global Antipsychotic Drugs Sales by Type (2015-2020)
4.1.2 Global Antipsychotic Drugs Revenue by Type (2015-2020)
4.1.3 Antipsychotic Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antipsychotic Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antipsychotic Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antipsychotic Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antipsychotic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antipsychotic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antipsychotic Drugs Market Size by Application (2015-2020)
5.1.1 Global Antipsychotic Drugs Sales by Application (2015-2020)
5.1.2 Global Antipsychotic Drugs Revenue by Application (2015-2020)
5.1.3 Antipsychotic Drugs Price by Application (2015-2020)
5.2 Antipsychotic Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antipsychotic Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antipsychotic Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antipsychotic Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antipsychotic Drugs by Country
6.1.1 North America Antipsychotic Drugs Sales by Country
6.1.2 North America Antipsychotic Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antipsychotic Drugs Market Facts & Figures by Type
6.3 North America Antipsychotic Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antipsychotic Drugs by Country
7.1.1 Europe Antipsychotic Drugs Sales by Country
7.1.2 Europe Antipsychotic Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antipsychotic Drugs Market Facts & Figures by Type
7.3 Europe Antipsychotic Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antipsychotic Drugs by Region
8.1.1 Asia Pacific Antipsychotic Drugs Sales by Region
8.1.2 Asia Pacific Antipsychotic Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antipsychotic Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antipsychotic Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antipsychotic Drugs by Country
9.1.1 Latin America Antipsychotic Drugs Sales by Country
9.1.2 Latin America Antipsychotic Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antipsychotic Drugs Market Facts & Figures by Type
9.3 Central & South America Antipsychotic Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antipsychotic Drugs by Country
10.1.1 Middle East and Africa Antipsychotic Drugs Sales by Country
10.1.2 Middle East and Africa Antipsychotic Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antipsychotic Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antipsychotic Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Antipsychotic Drugs Products Offered
11.1.5 AstraZeneca Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Antipsychotic Drugs Products Offered
11.2.5 Eli Lilly Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Antipsychotic Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Corporation Information
11.4.2 Johnson & Johnson Description and Business Overview
11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Johnson & Johnson Antipsychotic Drugs Products Offered
11.4.5 Johnson & Johnson Related Developments
11.5 Actavis Generics
11.5.1 Actavis Generics Corporation Information
11.5.2 Actavis Generics Description and Business Overview
11.5.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Actavis Generics Antipsychotic Drugs Products Offered
11.5.5 Actavis Generics Related Developments
11.6 Alkermes
11.6.1 Alkermes Corporation Information
11.6.2 Alkermes Description and Business Overview
11.6.3 Alkermes Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Alkermes Antipsychotic Drugs Products Offered
11.6.5 Alkermes Related Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Corporation Information
11.7.2 Bristol-Myers Squibb Description and Business Overview
11.7.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bristol-Myers Squibb Antipsychotic Drugs Products Offered
11.7.5 Bristol-Myers Squibb Related Developments
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description and Business Overview
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Antipsychotic Drugs Products Offered
11.1.5 AstraZeneca Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antipsychotic Drugs Market Estimates and Projections by Region
12.1.1 Global Antipsychotic Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antipsychotic Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antipsychotic Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antipsychotic Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antipsychotic Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antipsychotic Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antipsychotic Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antipsychotic Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antipsychotic Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antipsychotic Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antipsychotic Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antipsychotic Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antipsychotic Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antipsychotic Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antipsychotic Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antipsychotic Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antipsychotic Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antipsychotic Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antipsychotic Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antipsychotic Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antipsychotic Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antipsychotic Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antipsychotic Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antipsychotic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antipsychotic Drugs Market Segments
Table 2. Ranking of Global Top Antipsychotic Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antipsychotic Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of First Antipsychotic Drugs
Table 5. Major Manufacturers of Second Antipsychotic Drugs
Table 6. Major Manufacturers of Third Antipsychotic Drugs
Table 7. Global Antipsychotic Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Antipsychotic Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Antipsychotic Drugs Sales by Regions 2015-2020 (K Units)
Table 10. Global Antipsychotic Drugs Sales Market Share by Regions (2015-2020)
Table 11. Global Antipsychotic Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Antipsychotic Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Antipsychotic Drugs Sales Share by Manufacturers (2015-2020)
Table 14. Global Antipsychotic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Antipsychotic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipsychotic Drugs as of 2019)
Table 16. Antipsychotic Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Antipsychotic Drugs Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Antipsychotic Drugs Price (2015-2020) (USD/Unit)
Table 19. Antipsychotic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Antipsychotic Drugs Product Type
Table 21. Date of International Manufacturers Enter into Antipsychotic Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 24. Global Antipsychotic Drugs Sales Share by Type (2015-2020)
Table 25. Global Antipsychotic Drugs Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Antipsychotic Drugs Revenue Share by Type (2015-2020)
Table 27. Antipsychotic Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 29. Global Antipsychotic Drugs Sales Share by Application (2015-2020)
Table 30. North America Antipsychotic Drugs Sales by Country (2015-2020) (K Units)
Table 31. North America Antipsychotic Drugs Sales Market Share by Country (2015-2020)
Table 32. North America Antipsychotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Antipsychotic Drugs Revenue Market Share by Country (2015-2020)
Table 34. North America Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 35. North America Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Table 36. North America Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 37. North America Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Table 38. Europe Antipsychotic Drugs Sales by Country (2015-2020) (K Units)
Table 39. Europe Antipsychotic Drugs Sales Market Share by Country (2015-2020)
Table 40. Europe Antipsychotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Antipsychotic Drugs Revenue Market Share by Country (2015-2020)
Table 42. Europe Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 43. Europe Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Table 44. Europe Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 45. Europe Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Antipsychotic Drugs Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Antipsychotic Drugs Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Antipsychotic Drugs Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Antipsychotic Drugs Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Table 54. Latin America Antipsychotic Drugs Sales by Country (2015-2020) (K Units)
Table 55. Latin America Antipsychotic Drugs Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Antipsychotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Antipsychotic Drugs Revenue Market Share by Country (2015-2020)
Table 58. Latin America Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 59. Latin America Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Table 60. Latin America Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 61. Latin America Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Antipsychotic Drugs Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Antipsychotic Drugs Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Antipsychotic Drugs Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Antipsychotic Drugs Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Antipsychotic Drugs Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Antipsychotic Drugs Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Major Businesses
Table 72. AstraZeneca Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. AstraZeneca Product
Table 74. AstraZeneca Recent Development
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Major Businesses
Table 77. Eli Lilly Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Eli Lilly Product
Table 79. Eli Lilly Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Major Businesses
Table 82. GlaxoSmithKline Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Major Businesses
Table 87. Johnson & Johnson Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Recent Development
Table 90. Actavis Generics Corporation Information
Table 91. Actavis Generics Description and Major Businesses
Table 92. Actavis Generics Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Actavis Generics Product
Table 94. Actavis Generics Recent Development
Table 95. Alkermes Corporation Information
Table 96. Alkermes Description and Major Businesses
Table 97. Alkermes Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Alkermes Product
Table 99. Alkermes Recent Development
Table 100. Bristol-Myers Squibb Corporation Information
Table 101. Bristol-Myers Squibb Description and Major Businesses
Table 102. Bristol-Myers Squibb Antipsychotic Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Global Antipsychotic Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 106. Global Antipsychotic Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Antipsychotic Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Antipsychotic Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Antipsychotic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 110. North America: Antipsychotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Antipsychotic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 112. Europe: Antipsychotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Antipsychotic Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 114. Asia Pacific: Antipsychotic Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Antipsychotic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 116. Latin America: Antipsychotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Antipsychotic Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Middle East and Africa: Antipsychotic Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Antipsychotic Drugs Players
Table 123. Antipsychotic Drugs Customers List
Table 124. Antipsychotic Drugs Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Antipsychotic Drugs Product Picture
Figure 2. Global Antipsychotic Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. First Antipsychotic Drugs Product Picture
Figure 4. Second Antipsychotic Drugs Product Picture
Figure 5. Third Antipsychotic Drugs Product Picture
Figure 6. Global Antipsychotic Drugs Sales Market Share by Application in 2020 & 2026
Figure 7. Schizophrenia
Figure 8. Bipolar Disorder
Figure 9. Unipolar Depression
Figure 10. Dementia
Figure 11. Others
Figure 12. Antipsychotic Drugs Report Years Considered
Figure 13. Global Antipsychotic Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Antipsychotic Drugs Sales 2015-2026 (K Units)
Figure 15. Global Antipsychotic Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Antipsychotic Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Antipsychotic Drugs Sales Market Share by Region in 2019
Figure 18. Global Antipsychotic Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Antipsychotic Drugs Revenue Market Share by Region in 2019
Figure 20. Global Antipsychotic Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Antipsychotic Drugs Revenue in 2019
Figure 22. Antipsychotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Antipsychotic Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Antipsychotic Drugs Sales Market Share by Type in 2019
Figure 25. Global Antipsychotic Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Antipsychotic Drugs Revenue Market Share by Type in 2019
Figure 27. Global Antipsychotic Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Antipsychotic Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Antipsychotic Drugs Sales Market Share by Application in 2019
Figure 30. Global Antipsychotic Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Antipsychotic Drugs Revenue Market Share by Application in 2019
Figure 32. North America Antipsychotic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Antipsychotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Antipsychotic Drugs Sales Market Share by Country in 2019
Figure 35. North America Antipsychotic Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Antipsychotic Drugs Market Share by Type in 2019
Figure 41. North America Antipsychotic Drugs Market Share by Application in 2019
Figure 42. Europe Antipsychotic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Antipsychotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Antipsychotic Drugs Sales Market Share by Country in 2019
Figure 45. Europe Antipsychotic Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Antipsychotic Drugs Market Share by Type in 2019
Figure 57. Europe Antipsychotic Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Antipsychotic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Antipsychotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antipsychotic Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antipsychotic Drugs Revenue Market Share by Region in 2019
Figure 62. China Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Antipsychotic Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Antipsychotic Drugs Market Share by Application in 2019
Figure 86. Latin America Antipsychotic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Antipsychotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antipsychotic Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Antipsychotic Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Antipsychotic Drugs Market Share by Type in 2019
Figure 97. Latin America Antipsychotic Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Antipsychotic Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Antipsychotic Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Antipsychotic Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Antipsychotic Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Antipsychotic Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Antipsychotic Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Antipsychotic Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Antipsychotic Drugs Market Share by Application in 2019
Figure 110. North America Antipsychotic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Antipsychotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Antipsychotic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Antipsychotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Antipsychotic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Antipsychotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Antipsychotic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Antipsychotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Antipsychotic Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Antipsychotic Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
神経障害治療薬の世界市場（～2026年） Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively su…- 統合失調症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Schizophrenia Drugs Market The global Schizophrenia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Schizophrenia Drugs Scope and Market Size Schizophrenia Drugs market is seg…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- テネクテプラーゼ薬の世界市場（～2026年） Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. This enzyme is used to treat thrombus (blood clots) it is also called as clot-busting drug. Tenecteplase is a bioengineered variant of the activase drug. It is estimated that North America dominated the…
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…